Royalty Pharma
RPRX
#623
Rank
NZ$71.71 B
Marketcap
NZ$124.73
Share price
-0.01%
Change (1 day)
78.89%
Change (1 year)

Market capitalization of Royalty Pharma (RPRX)

Market cap: NZ$71.71 Billion

As of November 2026 Royalty Pharma has a market cap of NZ$71.71 Billion. This makes Royalty Pharma the world's 623th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Royalty Pharma from 2020 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$71.71 B81.6%
2025NZ$39.49 B48.01%
2024NZ$26.68 B0.19%
2023NZ$26.63 B-3%
2022NZ$27.45 B9.57%
2021NZ$25.05 B-6.93%
2020NZ$26.92 B

End of Day market cap according to different sources

On Nov 18th, 2026 the market cap of Royalty Pharma was reported to be:

NZ$71.54 Billion
by Nasdaq info icon info icon
NZ$71.71 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Abbott Laboratories
ABT
NZ$328.68 B 358.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$2.237 T 3,019.39%๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
NZ$2.95 B-95.89%๐Ÿ‡บ๐Ÿ‡ธ USA